Literature DB >> 31780005

Mindfulness-Based stress reduction in early palliative care for people with metastatic cancer: A mixed-method study.

Stefano Poletti1, Giorgia Razzini2, Roberto Ferrari3, Maria Pia Ricchieri4, Giorgio Alfredo Spedicato5, Antonella Pasqualini6, Cristina Buzzega7, Fabrizio Artioli8, Kyriakoula Petropulacos9, Mario Luppi10, Elena Bandieri11.   

Abstract

OBJECTIVES: To explore the impact of a Mindfulness-Based Stress Reduction (MBSR) intervention for people with metastatic cancer integrated in Early Palliative Care (EPC).
DESIGN: Mixed-method study. SETTINGS/LOCATION: EPC Service integrated with Oncology Unit, Carpi General Hospital, Italy from January to October 2017. The MBSR intervention took place inside the hospital.
SUBJECTS: Study participation was offered to 25 consecutive people referred to the EPC service. INCLUSION CRITERIA: people with metastatic cancer between 18 and 75 years old; informed consent. EXCLUSION CRITERIA: Performance Status <60% according to Karnofsky scale; active psychiatric disorder. 20 patients were included in the study. INTERVENTION: The adapted program consists of 8 meetings for 2.5 h once a week, a 4.5 h session between the 6th and 7th weeks and 0.5 h home practice daily. The following mindfulness practices were included during the training: formal sitting meditation, body scan, light yoga, walking meditation, and Aikido exercises. Participants were provided with materials for home practice. A qualified MBSR instructor conducted the program. Sessions were attended by a clinical psychologist and a physician trained in meditation, together with the palliative nurse as facilitators. OUTCOME MEASURES: Feasibility and acceptability were assessed on 16 participants. In addition, pre-post measures of cancer pain and mood state were collected. Semi-structured, in-depth interviews were conducted on a subset of 8 participants at the end of the study and analysed using the Interpretative-Phenomenological approach.
RESULTS: MBSR attendance to meetings and adherence to home practice were 75%. MBSR intervention helped participants to develop an accepting attitude in respect to metastatic cancer disease helping them to face anxiety and cancer pain. MBSR improves self-regulation of mood state engendering feelings of compassion MBSR program supports participants in questioning and reconnecting with their values and spiritual beliefs.
CONCLUSIONS: A Mindfulness intervention integrated into EPC setting is feasible, well accepted and could help metastatic cancer patients to control cancer pain together with an opportunity of emotional and spiritual relief.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Early palliative care; Integrative healthcare; Interpretive-phenomenological analysis; Metastatic cancer; Mindfulness-based stress reduction

Mesh:

Year:  2019        PMID: 31780005     DOI: 10.1016/j.ctim.2019.102218

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  4 in total

1.  Hybrid laser activated phycocyanin/capecitabine treatment of cancerous MCF7 cells.

Authors:  Sahar Jahdi Abdollahi; Parviz Parvin; Sara Mayahi; Solaleh Seyedi; Parnian Mohsenian; Fatemeh Ramezani
Journal:  Biomed Opt Express       Date:  2022-06-16       Impact factor: 3.562

2.  CORR Insights®: Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Metastatic Bone Disease from Lung Cancer? A Systematic Review and Network Meta-Analysis.

Authors:  Darin Davidson
Journal:  Clin Orthop Relat Res       Date:  2021-09-01       Impact factor: 4.755

3.  The Source of Life: Meditation and Spirituality in Healthcare for a Comprehensive Approach to The COVID-19 Syndemic.

Authors:  Guidalberto Bormolini; Annagiulia Ghinassi; Cecilia Pagni; Simona Milanese; Maria Martin de Ponzuelo
Journal:  Pastoral Psychol       Date:  2022-03-15

Review 4.  Mindfulness-Based Interventions in Cancer Survivors: A Systematic Review of Participants' Adherence to Home Practice.

Authors:  Mohamad Baydoun; Chelsea Moran; Andrew McLennan; Katherine-Ann L Piedalue; Devesh Oberoi; Linda E Carlson
Journal:  Patient Prefer Adherence       Date:  2021-06-09       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.